U.S. Military Launches Testosterone Screening for Service Members

Defense Secretary Pete Hegseth announced that the U.S. Armed Forces will begin screening active duty and reserve personnel for testosterone deficiency.

Under the new program, service members aged 30 or older will undergo annual blood tests, while younger soldiers may request testing at their discretion.

Those found to have low levels can receive voluntary replacement therapy, described by Pentagon officials as a way to preserve strength and resilience for both current deployments and post‑military life.

Hegseth emphasized that the program is not for artificial enhancement, and that non‑prescribed testosterone use remains prohibited.

Dr Mohit Khera, a pharmacist and FDA panel lead, said the screening is intended to detect health risks but cautioned against unnecessary hormone use because it can reduce fertility and may raise cardiovascular concerns.

The announcement follows moves by the administration to relax prescribing limits on testosterone and to address a reported national fertility crisis.

Experts argue the policy could improve soldier wellbeing but also raise ethical questions about medical interventions for performance enhancement.